Freakonomics Radio cover image

615. Is Ozempic as Magical as It Sounds?

Freakonomics Radio

CHAPTER

Ozempic: Breakthroughs and Challenges

This chapter explores the emergence of GLP-1 drugs like Ozempic, originally developed for type 2 diabetes, and their unexpected benefits for weight loss and various health issues. It addresses the complexities of the U.S. healthcare system, including drug costs, insurance coverage, and the long-term implications for patient health. The discussion also touches on advancements in medical research and the importance of balancing corporate interests with public health goals.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner